Clinical trials sponsored by Zhejiang University

Phase breakdown

Conditions studied

Recruiting trials led by Zhejiang University

• A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China
  NCT05886114 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years to 80 Years · Sex: All (male and female) · 1 location
• A Single-Arm, Phase II, Multicenter Clinical Study of Neoadjuvant Encorafenib Plus Cetuximab N01 and mFOLFOX6 in Patients With Locally Advanced BRAF V600E-Mutant Colorectal Cancer With or Without Resectable Metastases
  NCT07789210 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study to Evaluate Splenectomy on Debridement for Acute Necrotizing Pancreatitis With Pancreatic Sinistral Portal Hypertension
  NCT07080697 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
  NCT06937567 · Phase: Early Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• COMBO Endoscopy Oropharyngeal Airway Reduces Hypoxia During Sedated Gastrointestinal Endoscopy in Obese Patients: A Multicenter, Randomized, Controlled Clinical Trial
  NCT06796764 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 3 locations
• Combination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy for Morbidly Obese Patients
  NCT07175155 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Effects of Rectal Indomethacin Suppository on Postoperative CRBD in Patients Undergoing LRP
  NCT07607990 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: Male · 1 location
• Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery
  NCT06164769 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 70 Years · Sex: All (male and female) · 1 location
• Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study
  NCT07051980 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients
  NCT06770452 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation
  NCT07240766 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer
  NCT06770439 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
  NCT07359586 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 2 locations
• Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)
  NCT06220617 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or Without Resectable Metastases
  NCT07581912 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research
  NCT06711146 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
  NCT05731726 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• The Jiaxing Birth Cohort in China
  NCT03217656 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 2 locations
• The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer
  NCT07257653 · Phase: Phase 2 · Ages: 10 Years to 85 Years · Sex: All (male and female) · 1 location
• UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus
  NCT06920433 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Zhejiang University recruiting for?

Zhejiang University is the lead sponsor of 20 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.